13D Filing: Coliseum Capital and Blue Bird Corp (NASDAQ:BLBD)

---

CUSIP No. 095306106 (Common Stock)

Explanatory Note: This Amendment No. 3 (this Amendment) to the Schedule 13D (the Initial 13D) filed by the Filers (as
defined below) with the U.S. Securities and Exchange Commission (the Commission) on March 10, 2015, as amended and supplemented by Amendment No. 1 to the Initial 13D filed on February 16, 2017 and Amendment No. 2 to
the Initial 13D, filed on March 10, 2017, amends and supplements the items set forth herein.

As used in this statement, the term Filers
collectively refers to:

Coliseum Capital Management, LLC, a Delaware limited liability company (CCM);

Coliseum Capital, LLC, a Delaware limited liability company (CC);

Coliseum School Bus Holdings, LLC, a Delaware limited liability company (CSB);

Coliseum Capital Partners, L.P., a Delaware limited partnership (CCP);

Coliseum Capital Partners II, L.P., a Delaware limited partnership (CCP2);

Adam Gray, a director of the Issuer (Gray); and

Christopher Shackelton (Shackelton).

Item 5. Interest in Securities of the Issuer.

Item 5 is amended and supplemented as follows:

The
information relating to the beneficial ownership of shares of common stock, $0.0001 par value per share (the Common Shares) of Blue Bird Corporation (the Issuer) by each of the Filers set forth in Rows 7 through 13 of the
cover pages hereto is incorporated herein by reference. The percentages set forth in Row 13 for all cover pages filed herewith are calculated based upon 23,030,028 of Common Shares outstanding as of February 7, 2017, as reported in the
Issuers Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2016, filed with the Commission on February 9, 2017.

The Filers effected the following transactions in the Common Stock in open market transactions on the dates indicated, and such transactions are the only
transactions in the Common Stock by the Filers since the filing with the Commission of Amendment No. 2 to the Initial 13D on March 10, 2017.

Name		Purchase or Sale		Date				Number of Shares				Weighted Average Price Per Share
CCP		Sale			03/20/2017				287,392			$	17.00
CCP2		Sale			03/20/2017				72,844			$	17.00
Separate Account		Sale			03/20/2017				104,334			$	17.00
CCP		Sale			03/21/2017				30,922			$	17.00
CCP2		Sale			03/21/2017				7,841			$	17.00
Separate Account		Sale			03/21/2017				11,237			$	17.00

Except as set forth in Item 6 hereof, no other person has the right to receive or the power to direct the receipt of dividends
from, or the proceeds from the sale of, the Common Shares, the Issuers 7.625% Series A Convertible Cumulative Preferred Stock (the Series A Shares) or the Issuers warrants to purchase 0.5 common shares (the
Warrants) reported herein.

The information in Item 6 is incorporated herein by reference.

Page 9 of 11